Premium
SERUM BIOMARKERS ARE ASSOCIATED WITH TREATMENT RESPONSE IN RELAPSED MANTLE CELL LYMPHOMA
Author(s) -
Lokhande L.,
Emruli V.K.,
Kolstad A.,
Hutchings M.,
Räty R.,
Rodrigues J.D.,
Jerkeman M.,
Ek S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.72_2631
Subject(s) - mantle cell lymphoma , medicine , rituximab , ibrutinib , immune system , antibody , clinical trial , oncology , immunology , lymphoma , chronic lymphocytic leukemia , leukemia